Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer

Phase 2 Completed 32 enrolled Muhammad Furqan Celgene Corporation · collab

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this research study is to see if Abraxane and Gemcitabine given together will be effective in treating small cell cancer that has progressed after one line of treatment.

Timeline

Start: 2016-08-29
Primary completion: 2021-09-23
Completion: 2022-07-07

Publications

Byrne MM, Sutamtewagul G, Zeitler W, Mott SL, Zamba GKD, Kojadinovic A, Zhang J, Abu-Hejleh T, Clamon G, Furqan M. Phase II study of nab-paclitaxel with gemcitabine for relapsed/refractory small cell lung cancer. Front Oncol. 2024 Jul 31;14:1303268. doi: 10.3389/fonc.2024.1303268. eCollection 2024.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Gemcitabine	Small molecule	1000 mg/m2	Intravenous
Subject	Nab-paclitaxel	Small molecule	100 mg/m2	Intravenous

Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer

Summary

Timeline

Publications

Drugs

Indications